Kaitlin M Best1, Joseph I Boullata, Martha A Q Curley. 1. 1School of Nursing, University of Pennsylvania, Philadelphia, PA. 2Department of Biobehavioral Health Sciences, School of Nursing, University of Pennsylvania, Philadelphia, PA. 3Department of Family & Community Heath, School of Nursing, Philadelphia, PA.
Abstract
OBJECTIVES: Analgesia and sedation are common therapies in pediatric critical care, and rapid titration of these medications is associated with iatrogenic withdrawal syndrome. We performed a systematic review of the literature to identify all common and salient risk factors associated with iatrogenic withdrawal syndrome and build a conceptual model of iatrogenic withdrawal syndrome risk in critically ill pediatric patients. DATA SOURCES: Multiple databases, including PubMed/Medline, EMBASE, CINAHL, and the Cochrane Central Registry of Clinical Trials, were searched using relevant terms from January 1, 1980, to August 1, 2014. STUDY SELECTION: Articles were included if they were published in English and discussed iatrogenic withdrawal syndrome following either opioid or benzodiazepine therapy in children in acute or intensive care settings. Articles were excluded if subjects were neonates born to opioid- or benzodiazepine-dependent mothers, children diagnosed as substance abusers, or subjects with cancer-related pain; if data about opioid or benzodiazepine treatment were not specified; or if primary data were not reported. DATA EXTRACTION: In total, 1,395 articles were evaluated, 33 of which met the inclusion criteria. To facilitate analysis, all opioid and/or benzodiazepine doses were converted to morphine or midazolam equivalents, respectively. A table of evidence was developed for qualitative analysis of common themes, providing a framework for the construction of a conceptual model. The strongest risk factors associated with iatrogenic withdrawal syndrome include duration of therapy and cumulative dose. Additionally, evidence exists linking patient, process, and system factors in the development of iatrogenic withdrawal syndrome. FINDINGS: Most articles were prospective observational or interventional studies. CONCLUSIONS: Given the state of existing evidence, well-designed prospective studies are required to better characterize iatrogenic withdrawal syndrome in critically ill pediatric patients. This review provides data to support the construction of a conceptual model of iatrogenic withdrawal syndrome risk that, if supported, could be useful in guiding future research.
OBJECTIVES:Analgesia and sedation are common therapies in pediatric critical care, and rapid titration of these medications is associated with iatrogenic withdrawal syndrome. We performed a systematic review of the literature to identify all common and salient risk factors associated with iatrogenic withdrawal syndrome and build a conceptual model of iatrogenic withdrawal syndrome risk in critically ill pediatric patients. DATA SOURCES: Multiple databases, including PubMed/Medline, EMBASE, CINAHL, and the Cochrane Central Registry of Clinical Trials, were searched using relevant terms from January 1, 1980, to August 1, 2014. STUDY SELECTION: Articles were included if they were published in English and discussed iatrogenic withdrawal syndrome following either opioid or benzodiazepine therapy in children in acute or intensive care settings. Articles were excluded if subjects were neonates born to opioid- or benzodiazepine-dependent mothers, children diagnosed as substance abusers, or subjects with cancer-related pain; if data about opioid or benzodiazepine treatment were not specified; or if primary data were not reported. DATA EXTRACTION: In total, 1,395 articles were evaluated, 33 of which met the inclusion criteria. To facilitate analysis, all opioid and/or benzodiazepine doses were converted to morphine or midazolam equivalents, respectively. A table of evidence was developed for qualitative analysis of common themes, providing a framework for the construction of a conceptual model. The strongest risk factors associated with iatrogenic withdrawal syndrome include duration of therapy and cumulative dose. Additionally, evidence exists linking patient, process, and system factors in the development of iatrogenic withdrawal syndrome. FINDINGS: Most articles were prospective observational or interventional studies. CONCLUSIONS: Given the state of existing evidence, well-designed prospective studies are required to better characterize iatrogenic withdrawal syndrome in critically ill pediatric patients. This review provides data to support the construction of a conceptual model of iatrogenic withdrawal syndrome risk that, if supported, could be useful in guiding future research.
Authors: F Fernández-Carrión; M Gaboli; R González-Celador; P Gómez de Quero-Masía; S Fernández-de Miguel; V Murga-Herrera; O Serrano-Ayestarán; J M Sánchez-Granados; R Payo-Pérez Journal: Med Intensiva Date: 2012-05-17 Impact factor: 2.491
Authors: Erwin Ista; Monique van Dijk; Claudia Gamel; Dick Tibboel; Matthijs de Hoog Journal: Intensive Care Med Date: 2007-06-01 Impact factor: 17.440
Authors: D Rana; B Bellflower; J Sahni; A J Kaplan; N T Owens; E L Arrindell; A J Talati; R Dhanireddy Journal: J Perinatol Date: 2017-06-15 Impact factor: 2.521
Authors: Sapna R Kudchadkar; Othman Aljohani; Jordan Johns; Andrew Leroux; Eman Alsafi; Ebaa Jastaniah; Allan Gottschalk; Nehal J Shata; Ahmad Al-Harbi; Daniel Gergen; Anisha Nadkarni; Ciprian Crainiceanu Journal: J Pediatr Date: 2019-03-15 Impact factor: 4.406
Authors: Elyse M Cornett; Meskerem A Nemomsa; Bailey Turbeville; Matthew A Busby; Jessica S Kaye; Aaron J Kaye; JooHee Choi; Giovanni F Ramírez; Giustino Varrassi; Adam M Kaye; Alan D Kaye; James Wilson; Latha Ganti Journal: Health Psychol Res Date: 2022-10-12
Authors: Sebastiaan C Goulooze; Erwin Ista; Monique van Dijk; Dick Tibboel; Elke H J Krekels; Catherijne A J Knibbe Journal: AAPS J Date: 2021-05-17 Impact factor: 4.009
Authors: Anita K Patel; Eduardo Trujillo-Rivera; Farhana Faruqe; Julia A Heneghan; T Elizabeth Workman; Qing Zeng-Treitler; James Chamberlain; Hiroki Morizono; Dongkyu Kim; James E Bost; Murray M Pollack Journal: Pediatr Crit Care Med Date: 2020-09 Impact factor: 3.971